Works matching AU Kazumi Nishino

Results: 60
    1
    2
    3
    4
    5
    6

    Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection.

    Published in:
    Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 327, doi. 10.3892/mco.2017.1340
    By:
    • YUKI AKAZAWA;
    • MASAHIKO HIGASHIYAMA;
    • KAZUMI NISHINO;
    • JYUNJI UCHIDA;
    • TORU KUMAGAI;
    • TAKAKO INOUE;
    • AYAKO FUJIWARA;
    • TOSHITERU TOKUNAGA;
    • JIRO OKAMI;
    • FUMIO IMAMURA;
    • KEN KODAMA;
    • HISAYUKI KOBAYASHI
    Publication type:
    Article
    7
    8
    9
    10

    Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
    By:
    • Matsumoto, Kinnosuke;
    • Shiroyama, Takayuki;
    • Tamiya, Motohiro;
    • Minami, Toshiyuki;
    • Kinehara, Yuhei;
    • Tamiya, Akihiro;
    • Suga, Yasuhiko;
    • Kuge, Tomoki;
    • Mori, Masahide;
    • Suzuki, Hidekazu;
    • Tobita, Satoshi;
    • Ueno, Kiyonobu;
    • Namba, Yoshinobu;
    • Tetsumoto, Satoshi;
    • Niki, Toshie;
    • Morimura, Osamu;
    • Osa, Akio;
    • Nishino, Kazumi;
    • Nagatomo, Izumi;
    • Takeda, Yoshito
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Multiplex gene‐panel testing for lung cancer patients.

    Published in:
    Pathology International, 2020, v. 70, n. 12, p. 921, doi. 10.1111/pin.13023
    By:
    • Yatabe, Yasushi;
    • Sunami, Kuniko;
    • Goto, Koichi;
    • Nishio, Kazuto;
    • Aragane, Naoko;
    • Ikeda, Sadakatsu;
    • Inoue, Akira;
    • Kinoshita, Ichiro;
    • Kimura, Hideharu;
    • Sakamoto, Tomohiro;
    • Satouchi, Miyako;
    • Shimizu, Junichi;
    • Tsuta, Koji;
    • Toyooka, Shinichi;
    • Nishino, Kazumi;
    • Hatanaka, Yutaka;
    • Matsumoto, Shingo;
    • Mikubo, Masashi;
    • Yokose, Tomoyuki;
    • Dosaka‐Akita, Hirotoshi
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
    By:
    • Katakami, Nobuyuki;
    • Yokoyama, Toshihide;
    • Morita, Satoshi;
    • Okamoto, Tatsuro;
    • Urata, Yoshiko;
    • Hattori, Yoshihiro;
    • Iwamoto, Yasuo;
    • Sato, Yuki;
    • Ikeda, Norihiko;
    • Takahashi, Toshiaki;
    • Daga, Haruko;
    • Oguri, Tetsuya;
    • Fujisaka, Yasuhito;
    • Nishino, Kazumi;
    • Sugawara, Shunichi;
    • Kozuki, Toshiyuki;
    • Oki, Masahide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 13, p. 4501, doi. 10.1002/cam4.3089
    By:
    • Kunimasa, Kei;
    • Hirotsu, Yosuke;
    • Amemiya, Kenji;
    • Nagakubo, Yuki;
    • Goto, Taichiro;
    • Miyashita, Yoshihiro;
    • Kakizaki, Yumiko;
    • Tsutsui, Toshiharu;
    • Otake, Sotaro;
    • Kobayashi, Hiroaki;
    • Higuchi, Rumi;
    • Inomata, Kie;
    • Kumagai, Takashi;
    • Mochizuki, Hitoshi;
    • Nakamura, Harumi;
    • Nakatsuka, Shin‐ichi;
    • Nishino, Kazumi;
    • Imamura, Fumio;
    • Kumagai, Toru;
    • Oyama, Toshio
    Publication type:
    Article
    30

    Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58186-7
    By:
    • Tanaka, Kentaro;
    • Sugisaka, Jun;
    • Shiraishi, Yoshimasa;
    • Watanabe, Yasutaka;
    • Daga, Haruko;
    • Azuma, Koichi;
    • Nishino, Kazumi;
    • Mori, Masahide;
    • Ota, Takayo;
    • Saito, Haruhiro;
    • Hata, Akito;
    • Sakaguchi, Tadashi;
    • Kozuki, Toshiyuki;
    • Akamatsu, Hiroaki;
    • Matsumoto, Hirotaka;
    • Tachihara, Motoko;
    • Wakuda, Kazushige;
    • Sato, Yuki;
    • Ozaki, Tomohiro;
    • Tsuchiya-Kawano, Yuko
    Publication type:
    Article
    31
    32
    33

    A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
    By:
    • Hattori, Yoshihiro;
    • Iwasaku, Masahiro;
    • Satouchi, Miyako;
    • Nishiyama, Akihiro;
    • Korogi, Yohei;
    • Otsuka, Kojiro;
    • Fujita, Shiro;
    • Katakami, Nobuyuki;
    • Mori, Masahide;
    • Nishino, Kazumi;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    Article
    34
    35
    36
    37

    Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 21, p. 2970, doi. 10.1111/1759-7714.14643
    By:
    • Kunimasa, Kei;
    • Sugimoto, Naotoshi;
    • Kawamura, Takahisa;
    • Yamasaki, Tomoyuki;
    • Honma, Keiichiro;
    • Nagata, Shigenori;
    • Kukita, Yoji;
    • Fujisawa, Fumie;
    • Inoue, Tazuko;
    • Yamaguchi, Yuko;
    • Kitasaka, Mitsuko;
    • Wakamatsu, Toru;
    • Yamai, Takuo;
    • Yamamoto, Sachiko;
    • Hayashi, Takuji;
    • Inoue, Takako;
    • Tamiya, Motohiro;
    • Imamura, Fumio;
    • Nishimura, Kazuo;
    • Nishino, Kazumi
    Publication type:
    Article
    38
    39
    40
    41

    A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
    By:
    • Shibaki, Ryota;
    • Akamatsu, Hiroaki;
    • Kato, Terufumi;
    • Nishino, Kazumi;
    • Okada, Morihito;
    • Mitsudomi, Tetsuya;
    • Wakuda, Kazushige;
    • Yoshimura, Kenichi;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    42

    A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
    By:
    • Shibaki, Ryota;
    • Akamatsu, Hiroaki;
    • Kato, Terufumi;
    • Nishino, Kazumi;
    • Okada, Morihito;
    • Mitsudomi, Tetsuya;
    • Wakuda, Kazushige;
    • Yoshimura, Kenichi;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50